---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-26-013527"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2026-06-25T22:49:24+00:00"
generated_at: "2026-06-26T10:05:55.234512+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne to be acquired by Merck KGaA for $73.00 per share in all-cash deal

## Summary
- Merck KGaA to acquire Bio-Techne (TECH) for $73.00 per share in cash.
- Termination fees: Company pays $230.5M for superior proposal; Parent pays $576.1M for antitrust failure.
- Retention bonuses: CEO Kelderman $2.12M, CFO Hippel $1.54M, plus Geist $1.16M, Bohnen $0.97M, Crouse $0.91M.
- Closing requires shareholder approval, HSR and antitrust clearances; outside date Mar 25, 2027, extendable.
- Board unanimously recommends the merger; subject to no-shop and fiduciary-out provisions.

## SEC filing metadata
- accession: 0001999371-26-013527
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2026-06-25T22:49:24+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000199937126013527/0001999371-26-013527-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000199937126013527/tech-8k_062326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-26-013527
- JSON: https://secwatch.observer/filing/0001999371-26-013527.json
- Plain text: https://secwatch.observer/filing/0001999371-26-013527.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.